Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenues
Operating Expenses:
Personnel costs	69,181	30,470	200,125	91,754
Research and development expenses, related party	3,267	3,097	15,267	13,097
Professional fees	76,050	99,257	240,303	346,124
General and administrative expenses	26,925	12,257	64,076	41,210
Total operating expenses	175,423	145,081	519,771	492,185
Loss from operations	(175,423)	(145,081)	(519,771)	(492,185)
Other (Expenses):
Interest expense	(9,954)		(10,660)
Financing costs	(54,963)		(56,878)
Total other expenses	(64,917)		(67,538)
Loss before income taxes	(240,340)	(145,081)	(587,309)	(492,185)
Income taxes
Net loss	(240,340)	(145,081)	(587,309)	(492,185)
Deemed dividend on warrant modification		(3,548)		(3,548)
Net loss available to common stockholders	$ (240,340)	$ (148,629)	$ (587,309)	$ (495,733)
Net loss per common share:
Basic	$ (0.01)	$ (0.00)	$ (0.02)	$ (0.02)
Diluted	$ (0.01)	$ (0.00)	$ (0.02)	$ (0.02)
Weighted average common shares outstanding:
Basic	34,405,105	31,188,461	34,405,105	30,372,261
Diluted	34,405,105	31,188,461	34,405,105	30,372,261